
Anne Wojcicki Reacquires 23andMe and Its Data
Anne Wojcicki is reclaiming control of 23andMe by purchasing its assets through TTAM Research Institute for $305 million after the company's bankruptcy, surpassing an earlier bid from Regeneron Pharmaceuticals, amid ongoing privacy and profitability challenges.
